A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

被引：0
|
作者：
Congyu Shi
Shan Liu
Xudong Tian
Xiaoyi Wang
Pan Gao
机构：
[1] Sichuan University,State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology
[2] Sichuan University,State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of General and Emergency Dentistry, West China Hospital of Stomatology
来源：
BMC Cancer | / 21卷
关键词：
mutation; Head and neck squamous cell carcinoma; Prognosis; Immunotherapy; Chemotherapy; Therapeutic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
    Shi, Congyu
    Liu, Shan
    Tian, Xudong
    Wang, Xiaoyi
    Gao, Pan
    BMC CANCER, 2021, 21 (01)
  • [2] Significance of TP53 mutation in treatment and prognosis in head and neck squamous cell carcinoma
    Jin, Yu
    Qin, Xing
    BIOMARKERS IN MEDICINE, 2021, 15 (01) : 15 - 28
  • [3] Predicting therapeutic responses in head and neck squamous cell carcinoma from TP53 mutation detected by cell-free DNA
    Wei, Mei
    Zhi, Jingtai
    Li, Li
    Wang, Wei
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (12) : 3604 - 3617
  • [4] TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck
    Alsner, J
    Sorensen, SB
    Overgaard, J
    RADIOTHERAPY AND ONCOLOGY, 2001, 59 (02) : 179 - 185
  • [5] A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
    Xu, Feng
    Lin, Haoyu
    He, Pei
    He, Lulu
    Chen, Jiexin
    Lin, Ling
    Chen, Yongsong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [6] A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
    Meng, Zilu
    Yang, Wenhan
    Zhu, Lei
    Liu, Wanyu
    Wang, Yudong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] TP53 genetic heterogeneity in recurrent or second primary head and neck squamous cell carcinoma
    Kampel, Liyona
    Feldstein, Sara
    Tsuriel, Shlomo
    Trejo, Leonor Leider
    Horowitz, Gilad
    Warshavsky, Anton
    Mansour, Jobran
    Hershkovitz, Dov
    Muhanna, Nidal
    RADIOTHERAPY AND ONCOLOGY, 2025, 204
  • [8] TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
    Zhou, Ge
    Liu, Zhiyi
    Myers, Jeffrey N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (12) : 2682 - 2692
  • [9] In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
    Burcher, Kimberly M.
    Wilson, Harper L.
    Gavrila, Elena
    Abreu, Arianne
    D'Agostino, Ralph B., Jr.
    Zhang, Wei
    Porosnicu, Mercedes
    ONCOLOGIST, 2022, 27 (07) : E606 - E607
  • [10] Interaction between potential doubling time and TP53 mutation:: Predicting radiotherapy outcome in squamous cell carcinoma of the head and neck
    Alsner, J
    Hoyer, M
    Sorensen, SB
    Overgaard, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (02): : 519 - 525
12345